http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21460971

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article
endingPage 448
issn 1432-0843
0344-5704
issueIdentifier 3
pageRange 441-448
publicationName Cancer Chemotherapy and Pharmacology
startingPage 441
bibliographicCitation Chiorean EG, Malireddy S, Younger AE, Jones DR, Waddell MJ, Sloop MI, Yu M, Hall SD, Schneider B, Sweeney CJ. A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2010 Aug;66(3):441–8. doi: 10.1007/s00280-009-1179-2. PMID: 20091169.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0083614a8b1b5a336c91f447641c82be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c22bbbb5105a1e78e73e4e05a07cd66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5efa6dbb38c161d230948b17ec640af8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1df03dd20ac92c7facd81e4bc6b30dd1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e3e36353135394a9a329cb1cdf6ed8a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4d9e49e23f033b21c894d98a677434d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_001434985c4562fe04708ea8ee713b76
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ed55c3ee4d2eedc3e13fdf914f11ce7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02168b01e2e8266f3623398352adcd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab7ca14ae22b763ff9bac14d51f9dc62
date 2009-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00280-009-1179-2
https://pubmed.ncbi.nlm.nih.gov/20091169
isPartOf https://portal.issn.org/resource/ISSN/0344-5704
https://portal.issn.org/resource/ISSN/1432-0843
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors
discusses http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0016766
http://id.nlm.nih.gov/mesh/M0000972
http://id.nlm.nih.gov/mesh/M0358615
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22386467
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a236e0877bf928b9d51ea42ef63147c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330

Total number of triples: 43.